Elevated Exhaled Nitric Oxide in Allergen-Provoked Asthma Is Associated with Airway Epithelial iNOS

Background Fractional exhaled nitric oxide is elevated in allergen-provoked asthma. The cellular and molecular source of the elevated fractional exhaled nitric oxide is, however, uncertain. Objective To investigate whether fractional exhaled nitric oxide is associated with increased airway epithelial inducible nitric oxide synthase (iNOS) in allergen-provoked asthma. Methods Fractional exhaled nitric oxide was measured in healthy controls (n = 14) and allergic asthmatics (n = 12), before and after bronchial provocation to birch pollen out of season. Bronchoscopy was performed before and 24 hours after allergen provocation. Bronchial biopsies and brush biopsies were processed for nitric oxide synthase activity staining with nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d), iNOS immunostaining, or gene expression analysis of iNOS by real-time PCR. NADPH-d and iNOS staining were quantified using automated morphometric analysis. Results Fractional exhaled nitric oxide and expression of iNOS mRNA were significantly higher in un-provoked asthmatics, compared to healthy controls. Allergic asthmatics exhibited a significant elevation of fractional exhaled nitric oxide after allergen provocation, as well as an accumulation of airway eosinophils. Moreover, nitric oxide synthase activity and expression of iNOS was significantly increased in the bronchial epithelium of asthmatics following allergen provocation. Fractional exhaled nitric oxide correlated with eosinophils and iNOS expression. Conclusion Higher fractional exhaled nitric oxide concentration among asthmatics is associated with elevated iNOS mRNA in the bronchial epithelium. Furthermore, our data demonstrates for the first time increased expression and activity of iNOS in the bronchial epithelium after allergen provocation, and thus provide a mechanistic explanation for elevated fractional exhaled nitric oxide in allergen-provoked asthma.

[1]  R. Jörres,et al.  FENO measurement and sputum analysis for diagnosing asthma in clinical practice. , 2013, Respiratory medicine.

[2]  A. Michils,et al.  Axial distribution of nitric oxide airway production in asthma patients , 2013, Respiratory Physiology & Neurobiology.

[3]  D. Christiani,et al.  Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the US general population: results from the National Health and Nutrition Examination Survey 2007-2010. , 2013, Chest.

[4]  D. Hui,et al.  Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population , 2012, European Respiratory Journal.

[5]  A. Malinovschi,et al.  The fraction of NO in exhaled air and estimates of alveolar NO in adolescents with asthma: Methodological aspects , 2012, Pediatric pulmonology.

[6]  S. Gabrielsson,et al.  Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma , 2012, Allergy.

[7]  S. Wenzel,et al.  Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  P. Sterk,et al.  Exhaled Nitric Oxide is Related to Bronchial Eosinophilia and Airway Hyperresponsiveness to Bradykinin in Allergen-Induced Asthma Exacerbation , 2012, International journal of immunopathology and pharmacology.

[9]  S. Willsie.  Daily exhaled nitric oxide measurements and asthma exacerbations in children , 2012 .

[10]  S. Quirce,et al.  Changes in Exhaled Nitric Oxide Levels After Bronchial Allergen Challenge , 2012, Lung.

[11]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[12]  N. Fineberg,et al.  Elevated levels of NO are localized to distal airways in asthma. , 2011, Free radical biology & medicine.

[13]  C. Bucca,et al.  The increase in exhaled NO following allergen challenge is not associated with airway acidification , 2011, European journal of clinical investigation.

[14]  Å. Wheelock,et al.  Increased pulmonary Wnt (wingless/integrated)-signaling in patients with sarcoidosis. , 2011, Respiratory medicine.

[15]  J. Grunewald,et al.  Allergen provocation increases TH2‐cytokines and FOXP3 expression in the asthmatic lung , 2010, Allergy.

[16]  P. Barnes,et al.  Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients. , 2009, Chest.

[17]  J. L. Puckett,et al.  Partitioned exhaled nitric oxide to non-invasively assess asthma , 2008, Respiratory Physiology & Neurobiology.

[18]  T. Haahtela,et al.  Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide , 2008, The clinical respiratory journal.

[19]  S. Wenzel,et al.  IL‐13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  A. Woodcock,et al.  Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. , 2007, American journal of respiratory and critical care medicine.

[21]  J. Bousquet,et al.  Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. , 2007 .

[22]  M. Müller,et al.  Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects , 2006, European Respiratory Journal.

[23]  D. Knight,et al.  Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath , 2004, Thorax.

[24]  Mary Jane Thomassen,et al.  Regulation of No Synthesis Transcriptional and Post-translational Oxide (no) in Asthma: Evidence for Molecular Mechanisms of Increased Nitric , 2013 .

[25]  B. Gaston,et al.  Endogenous airway acidification. Implications for asthma pathophysiology. , 2000, American journal of respiratory and critical care medicine.

[26]  P. Thompson,et al.  Expression and activity of nitric oxide synthases in human airway epithelium. , 1997, American journal of respiratory cell and molecular biology.

[27]  P. Barnes,et al.  Nitric oxide as a neurotransmitter in human airways. , 1995, Archives internationales de pharmacodynamie et de therapie.

[28]  F. Sundler,et al.  Mucosal nitric oxide may tonically suppress airways plasma exudation. , 1994, American journal of respiratory and critical care medicine.

[29]  S. Dahlén,et al.  The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. , 1994, The European respiratory journal.

[30]  P. J. Barnes,et al.  Increased nitric oxide in exhaled air of asthmatic patients , 1994, The Lancet.

[31]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[32]  S. Vincent,et al.  Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Eklund,et al.  Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. , 1986, Thorax.